An autoimmune disease-associated risk variant in the TNFAIP3 gene plays a protective role 1 in brucellosis that is mediated by the NF-kappa B signaling pathway 2
暂无分享,去创建一个
Yang Wang | Hongxiao Song | Kaiyu Zhang | Z. Tu | Xianjun Liu | Shaofeng Wang | Wanguo Bao | Lixin Lou | Hai-Peng Li | Haijun Li
[1] D. Ye,et al. Associations between TNFAIP3 gene polymorphisms and systemic lupus erythematosus risk: an updated meta‐analysis , 2016, HLA.
[2] Mai Moaaz,et al. Association of the polymorphisms of TRAF1 (rs10818488) and TNFAIP3 (rs2230926) with rheumatoid arthritis and systemic lupus erythematosus and their relationship to disease activity among Egyptian patients , 2016, Central-European journal of immunology.
[3] W. El-Baz,et al. CD28 and PTPN22 are associated with susceptibility to rheumatoid arthritis in Egyptians. , 2016, Human immunology.
[4] P. Gaffney,et al. TALEN-mediated enhancer knockout influences TNFAIP3 gene expression and mimics a molecular phenotype associated with systemic lupus erythematosus , 2016, Genes and Immunity.
[5] Xu Wang,et al. Characteristics of A20 gene polymorphisms and clinical significance in patients with rheumatoid arthritis , 2015, Journal of Translational Medicine.
[6] Yasong Li,et al. TNFAIP3 rs2230926 polymorphisms in rheumatoid arthritis of southern Chinese Han population: a case-control study. , 2014, International journal of clinical and experimental pathology.
[7] 門田 景介. Analysis of gender differences in genetic risk : association of TNFAIP3 polymorphism with male childhood-onset systemic lupus erythematosus in the Japanese population , 2014 .
[8] C. Dinarello,et al. Treating inflammation by blocking interleukin-1 in humans. , 2013, Seminars in immunology.
[9] P. Gaffney,et al. An Enhancer Element Harboring Variants Associated with Systemic Lupus Erythematosus Engages the TNFAIP3 Promoter to Influence A20 Expression , 2013, PLoS genetics.
[10] S. Bae,et al. Pathway analysis of genome-wide association studies on rheumatoid arthritis. , 2013, Clinical and experimental rheumatology.
[11] 鈴木 拓. PADI4 and HLA-DRB1 are genetic risks for radiographic progression in RA patients, independent of ACPA status : results from the IORRA cohort study(本文) , 2013 .
[12] A. Ma,et al. A20: linking a complex regulator of ubiquitylation to immunity and human disease , 2012, Nature Reviews Immunology.
[13] S. Bae,et al. Associations between TNFAIP3 gene polymorphisms and rheumatoid arthritis: a meta-analysis , 2012, Inflammation Research.
[14] Debashis Ghosh,et al. Proinflammatory Caspase-2-Mediated Macrophage Cell Death Induced by a Rough Attenuated Brucella suis Strain , 2011, Infection and Immunity.
[15] D. Ye,et al. The association between BANK1 and TNFAIP3 gene polymorphisms and systemic lupus erythematosus: a meta‐analysis , 2011, International journal of immunogenetics.
[16] G. Pappas,et al. Cell-mediated immunity in human brucellosis. , 2011, Microbes and infection.
[17] A. Kawasaki,et al. Association of TNFAIP3 Polymorphism with Susceptibility to Systemic Lupus Erythematosus in a Japanese Population , 2010, Journal of biomedicine & biotechnology.
[18] A. De La Hera,et al. Human Brucellosis Is Characterized by an Intense Th1 Profile Associated with a Defective Monocyte Function , 2010, Infection and Immunity.
[19] Yusuke Nakamura,et al. The association of a nonsynonymous single-nucleotide polymorphism in TNFAIP3 with systemic lupus erythematosus and rheumatoid arthritis in the Japanese population. , 2010, Arthritis and rheumatism.
[20] I. Baydar,et al. TNF-alpha, TGF-beta, IL-10, IL-6 and IFN-gamma gene polymorphisms as risk factors for brucellosis. , 2009, The new microbiologica.
[21] Pui-Yan Kwok,et al. Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus , 2008, Nature Genetics.
[22] S. Oliveira,et al. The role of innate immune receptors in the control of Brucella abortus infection: toll-like receptors and beyond. , 2008, Microbes and infection.
[23] C. Guzmán-Verri,et al. Brucella abortus Uses a Stealthy Strategy to Avoid Activation of the Innate Immune System during the Onset of Infection , 2007, PloS one.
[24] R. Goenka,et al. Host immune responses to the intracellular bacteria Brucella: does the bacteria instruct the host to facilitate chronic infection? , 2006, Critical reviews in immunology.
[25] M. J. Bravo,et al. Polymorphisms of the interferon gamma and interleukin 10 genes in human brucellosis. , 2003, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.
[26] J. Oliaro,et al. The innate immune response against Brucella in humans. , 2002, Veterinary microbiology.
[27] Ashok Kumar,et al. Nef Protein of Human Immunodeficiency Virus and Lipopolysaccharide Induce Expression of CD14 on Human Monocytes through Differential Utilization of Interleukin-10 , 2002, Clinical and Vaccine Immunology.
[28] D. Scott,et al. Immunity and protection against Brucella abortus. , 2001, Microbes and infection.
[29] R. Beyaert,et al. A20 and A20-binding proteins as cellular inhibitors of nuclear factor-kappa B-dependent gene expression and apoptosis. , 2000, Biochemical pharmacology.
[30] A. Kelso,et al. Differential activation of Brucella-reactive CD4+ T cells by Brucella infection or immunization with antigenic extracts , 1995, Infection and immunity.